Clinically meaningful performance benchmarks in MS:Timed 25-Foot Walk and the real world

Neurology

Volumn 81, Issue 21, 2013, Pages 1856-1863

  Goldman, Myla D ^a   Motl, Robert W ^b   Scagnelli, John ^c   Pula, John H ^d   Sosnoff, Jacob J ^b   Cadavid, Diego ^e  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c Raleigh Neurology Associates   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

^e BIOGEN   (United States)

Author keywords

6MWT Six Minute Walk Test; EDSS Expanded Disability Status Scale; IADL instrumental activities of daily living; LL FDI Late Life Function and Disability Inventory; MS multiple sclerosis; MSWS 12 Multiple Sclerosis Walking Scale 12; O2cost oxygencost of walking; PASAT Paced Auditory Serial Addition Task; PS Performance Scales; SDMT Symbol Digit ModalitiesTest; SI Symptom Inventory; SSST Six Spot Step Test; T25FW Timed 25 Foot Walk; TUG Timed Up and Go

Indexed keywords

ACCELEROMETER; ADL DISABILITY; ADULT; ARTICLE; CANE; CLINICAL EVALUATION; COGNITION; CROSS-SECTIONAL STUDY; DISEASE COURSE; EMPLOYMENT STATUS; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOOD PROCESSING; FUNCTION TEST; GAIT; GOVERNMENT; HEALTH CARE SURVEY; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOBILIZATION; MULTIPLE SCLEROSIS; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE VALUE; SCORING SYSTEM; SELF REPORT; TIMED 25 FOOT WALK PERFORMANCE; WALKER;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; EMPLOYMENT; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; WALKING;

EID: 84891941666     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000436065.97642.d2     Document Type: Article

References (39)

1. Heesen C, Böhm J, Reich C, Kasper J, Goebel M, Gold S. Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable. Mult Scler 2008;14:988-991.
2. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. New Engl J Med 2000;343:1430-1438.
3. Larocca N. Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners. Patient 2011;4:189-201.
4. Kiesseier B, Pozzilli C. Assessing walking disability in multiple sclerosis. Mult Scler 2012;18:914-924.
5. Goodman AD, Brown T, Krupp LB, et al. Sustainedrelease oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet 2009;373:732-738.
6. Goodman AD, Cohen J, Cross A, et al. Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebocontrolled, dose ranging study.Mult Scler 2007;13:357-368.
7. Coleman C, Sobieraj D, Marinucci L. Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis. Curr Med Res Opin 2012;28:49-56.
8. Kaufman M, Moyer D, Norton J. The significant change for the Timed 25-Foot Walk in the multiple sclerosis functional composite. Mult Scler 2000;6:286-290.
9. Schwid SR, Goodman AD, McDermott MP, Bever CF, Cook SD. Quantitative functional measures in MS: what is a reliable change? Neurology 2002;58:1294-1296.
10. Kragt J, Van der Linden F, Nielsen J, Uitdehagg B, Polman C. Clinical impact of 20% worsening on Timed 25-Foot Walk and 9-Hole Peg Test in multiple sclerosis. Mult Scler 2006;12:594-598.
11. Bosma L, Kragt J, Knol D, Polman C, Uitdehaag B. Clinical scales in progressive MS: predicting long-term disability. Mult Scler 2012;18:345-350.
12. Orbach R, Zhao Z, Wang Y, O'Neill G, Cadavid D. Comparison of disease activity in SPMS and PPMS in the context of multicenter clinical trials. PLoS One 2012;7:e45409.
13. Benedict R, Cookfair D, Gavett R, et al. Validity of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). J Int Neuropsychol Soc 2006;12:549-558.
14. Lawton M, Brody E. Assessment of older people: selfmaintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
15. Marrie R, Goldman M. Validity of performance scales for disability assessment in multiple sclerosis. Mult Scler 2007;13:1176-1182.
16. Schwartz C, Volmer T, Lee H. Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Study Group. Neurology 1999;52:63-70.
17. McGuigan C, Hutchinson M. Confirming the validity and responsiveness of the Multiple Sclerosis Walking Scale-12 (MSWS-12). Neurology 2004;62:2103-2105.
18. Motl RW, Snook EM. Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12). J Neurol Sci 2008;268:69-73.
19. Hobart J, Riazi A, Lamping D, Fitzpatrick R, Thompson A. Measuring the impact of MS on walking ability. Neurology 2003;60:31-36.
20. Benedict R, Fishman I, McClellan M, Bakshi R, Weinstock-Guttman B. Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis. Mult Scler 2003;9:393-396.
21. Beck A, Steer R, Brown G, editors. BDI-FastScreen for Medical Patients Manual. San Antonio: The Psychological Corporation; 2000.
22. Nilsagard Y, Lundholm C, Gunnarsson L, Dcnison E. Clinical relevance using timed walk tests and "timed up and go" testing in persons with multiple sclerosis. Physiother Res Int 2007;12:105-114.
23. Nieuwenhuis M, Van Tongeren H, Sorensen P, Ravnborg M. The Six Spot Step Test: a new measurement for walking ability in multiple sclerosis. Mult Scler 2006; 12:495-500.
24. Goldman M, Marrie R, Cohen J. Evaluation of the Six-Minute Walk in multiple sclerosis subjects and healthy controls. Mult Scler 2008;14:383-390.
25. Heffernan K, Ranadive S, Weikert M, et al. Pulse pressure is associated with walking impairment in multiple sclerosis. J Neurol Sci 2011;309:105-109.
26. Motl R, Suh Y, Dlugonski D, et al. Oxygen cost of treadmill and over-ground walking in mildly disabled persons with multiple sclerosis. Neurol Sci 2011;32:255-262.
27. Motl R, Dlugonski D, Weikert M, Agiovlasitis S, Fernhall B, Goldman M. Multiple Sclerosis Walking Scale-12 and oxygen cost of walking. Gait Posture 2010; 31:506-510.
28. Sosnoff J, Sandroff B, Motl R. Quantifying gait abnormalities in persons with multiple sclerosis with minimal disability. Gait Posture 2012;36:154-156.
29. Sosnoff J, Weikert M, Dlugonski D, Smith D, Motl R. Quantifying gait impairment in multiple sclerosis using GAITRite technology. Gait Posture 2011;34: 145-147.
30. Drake A, Weinstock-Guttman B, Morrow S, Hojnacki D, Munschauer F, Benedict R. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test. Mult Scler 2010;16:228-237.
31. Fischer JS, Rudick RA, Cutter GR, Reingold SC; National MS Society Clinical Outcomes Assessment Task Force. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler 1999;5:244-250.
32. Gordon-Lipkin E, Chodkowski B, Reich D, et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 2007;69:1603-1609.
33. Motl R, McAuley E, Suy Y. Validity, invariance, and responsiveness of a self-report measure of functional limitations and disability in multiple sclerosis. Disabil Rehabil 2010;32:1260-1271.
34. Asch D, Jedrziewski M, Christakis N. Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997;50:1129-1136.
35. Goverover Y, Chiaravalloti N, Gaudino-Goering E, Moore N, DeLuca J. The relationship among performance of instrumental activities of daily living, self-report of quality of life, and self-awareness of functional status in individuals with multiple sclerosis. Rehabil Psychol 2009;54: 60-68.
36. Scheinberg L, Holland N, Larocca N, Laitin P, Bennett A, Hall H. Multiple sclerosis: earning a living. NY State J Med 1980;80:1395-1400.
37. Sherbourne C, Hays R. Marital status, social support, and health transitions in chronic disease patients. J Health Soc Behav 1990;31:328-343.
38. Slater A, Cutter G, Tyry T, Marrie R, Volmer T. Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS. Curr Med Res Opin 2010;26:493-500.
39. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-1452.